Word: weissman
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...innovation to biasing research is far from simple. “The influence of industry in academia is really a double-edged sword because professors may know a lot about gene expression but not a lot about manufacturing and marketing,” said study co-author Joel S. Weissman, an associate professor at HMS. “But a lot of people are starting to realize that the influence of drug companies in health care is pervasive and may be more than we want it to be.” According to Marjorie E. Powell, senior assistant general counsel...
...world’s challenges from an international perspective. In fall 2002, he enrolled at Harvard, where his experiences in Zimbabwe and Norway led him to choose Social Studies as his concentration. In his sophomore summer, Robinson taught English to Tibetan refugee children in India, thanks to the Weissman International Internship Program. He said that the experience made him “appreciate the importance of education.” Although it was it was he who did most of the learning there, he added. The following summer, Robinson went to Germany and realized that he wanted...
...three months before Meat’s death, Daniel B. Weissman ’05 wrote, “holy shit, you’re alive. what’s going on?” A couple posts later someone asks, “are you coming back for the POWWOW...
...Weissman and others are finding no shortage of targets. For one thing, cancer stem cells seem to be extremely mobile, able to migrate easily from their birthplace to other parts of the body, where they can churn out more stem cells and launch new tumors. Eradicating those cells at their source might help control the spread of cancers like leukemia that flare from the blood to the bone marrow and other tissues. Blocking a stem cell's source of nutrients might be another effective strategy for drug development. Unlike normal stem cells, which tap into many different blood supplies...
...rapidly, thanks in part, paradoxically, to President George W. Bush's restrictions on embryonic-stem-cell research. Some of the federal funds that might otherwise have gone to embryonic stem cells could be finding their way into cancer-stem-cell studies. "Don't expect anything before five years," says Weissman, "but be angry if you don't see anything in 15 years." Cancer patients, mark your calendars...